Publications by authors named "David Hermanson"

Claim this Profile
T
The need for an organoid manufacturing, preservation, and distribution center.
Anthony Atala, John C Bischof, Christopher S Chen, John P Fisher, David L Hermanson

Stem Cells Transl Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor-natural killer cells.
Mark Gurney, Eimear O'Reilly, Sarah Corcoran, Sarah Brophy, Janusz Krawczyk, David L Hermanson

Cytotherapy· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity.
Ye Li, David L Hermanson, Branden S Moriarity, Dan S Kaufman

Cell Stem Cell· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse Xenograft Model for Intraperitoneal Administration of NK Cell Immunotherapy for Ovarian Cancer.
David L Hermanson, Laura Bendzick, Dan S Kaufman

Methods Mol Biol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer.
David L Hermanson, Laura Bendzick, Lee Pribyl, Valarie McCullar, Rachel Isaksson Vogel

Stem Cells· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing chimeric antigen receptors to direct natural killer cell activity.
David L Hermanson, Dan S Kaufman

Front Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.
Melissa A Geller, David A Knorr, David A Hermanson, Lee Pribyl, Laura Bendzick

Cytotherapy· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of Mcl-1 confers multidrug resistance, whereas topoisomerase IIβ downregulation introduces mitoxantrone-specific drug resistance in acute myeloid leukemia.
David L Hermanson, Sonia G Das, Yunfang Li, Chengguo Xing

Mol Pharmacol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy.
David A Knorr, Zhenya Ni, David Hermanson, Melinda K Hexum, Laura Bendzick

Stem Cells Transl Med· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017): a novel scaffold that resensitizes multidrug resistant leukemia cells to chemotherapy.
Sonia G Das, David L Hermanson, Nicholas Bleeker, Xazmin Lowman, Yunfang Li

ACS Chem Biol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship (SAR) study of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and the potential of the lead against multidrug resistance in cancer treatment.
Gopalakrishnan Aridoss, Bo Zhou, David L Hermanson, Nicholas P Bleeker, Chengguo Xing

J Med Chem· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung tumorigenesis suppressing effects of a commercial kava extract and its selected compounds in A/J mice.
Thomas E Johnson, David Hermanson, Lei Wang, Fekadu Kassie, Pramod Upadhyaya

Am J Chin Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship and molecular mechanisms of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and its analogues.
Sonia G Das, Balasubramanian Srinivasan, David L Hermanson, Nicholas P Bleeker, Jignesh M Doshi

J Med Chem· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
Ahmad Ali Shaik, David Lee Hermanson, Chengguo Xing

Bioorg Med Chem Lett· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship and molecular mechanisms of ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4h-chromene-3-carboxylate (sha 14-1) and its analogues.
Sonia G Das, Jignesh M Doshi, Defeng Tian, Sadiya N Addo, Balasubramanian Srinivasan, David L Hermanson

J Med Chem· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria.
David Hermanson, Sadiya N Addo, Anna A Bajer, Jonathan S Marchant, Sonia Goutam Kumar Das

Mol Pharmacol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis